Amissa
Techstars '26Charlotte, US · 14 employees on LinkedIn · 2 known investors
Amissa Health quantifies symptoms through wearable data and biometric collection to improve clinical care and research, with a focus on early detection of Alzheimer's and digital biomarkers for perimenopause in women. The company serves healthcare institutions, researchers, and patients seeking personalized treatment guidance.
Founders & leadership
SS
Sam SmithFounder & CEO
JC
Jon CorkeyFounder & CSO
Board
DJ
Dr. Jaclyn PiastaFounder, Monarch Health
Investors · 2
Competitors · 6
by search overlap
Alloy802 shared keywordsAlloy is a telehealth service that connects women in midlife and menopause with board-certified, menopause-trained doctors for treatments including hormone therapy, GLP-1 weight care, skincare, sexual health, hair and gut health. It offers online intake, ongoing messaging with physicians, and cash-pay/FSA-HSA-eligible prescription products.
Flo Health736 shared keywordsFlo is a women's health app offering personalized cycle tracking, fertility guidance, pregnancy support, and health education backed by a medical team. The app serves women and people with periods globally with science-based insights on hormonal health from first period to perimenopause.
Evernow674 shared keywordsEvernow provides virtual menopause care for women, offering one-time video visits and ongoing membership access to certified menopause providers who prescribe hormone therapy and estrogen replacement. It also sells medically curated supplements targeting menopause symptoms such as sleep, mood, energy, skin, and metabolism.
Midi Health629 shared keywordsMIDI develops digital health solutions for patients and clinicians to improve access to and delivery of care across diverse populations. The company takes an experimental approach to building tools that address unmet clinical needs.
Gennev550 shared keywordsGennev is a telehealth clinic focused on menopause care, offering video appointments with board-certified, menopause-trained doctors and evidence-based treatment for women from perimenopause through post-menopause. It provides symptom relief, medical questionnaires, and insurance-based payment options.
Natural Cycles516 shared keywordsNatural Cycles offers an FDA-cleared mobile app that uses a user's body temperature data and an algorithm to predict fertile windows for hormone-free birth control and pregnancy planning. The app supports women's health across life stages from contraception through perimenopause and is certified in over 35 countries.
Companies competing with Amissa for the same Google search keywords, organic and paid, via search-intersection analysis.
Non-dilutive funding · 1 SBIR/STTR award
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2021 | $495.8K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
In the news
Frequently asked questions
- What does Amissa do?
- Amissa Health quantifies symptoms through wearable data and biometric collection to improve clinical care and research, with a focus on early detection of Alzheimer's and digital biomarkers for perimenopause in women. The company serves healthcare institutions, researchers, and patients seeking personalized treatment guidance.
- Who founded Amissa?
- Amissa was founded by Sam Smith, Jon Corkey.
- Who are Amissa's investors?
- Amissa's investors include Primordial Ventures, Techstars.
- Where is Amissa headquartered?
- Amissa is headquartered in Charlotte, US.